Capillary Recovery in Scleroderma After Stem Cell Therapy
Author Information
Author(s): Fleming Jo N., Nash Richard A., McLeod D. O., Fiorentino David F., Shulman Howard M., Connolly M. Kari, Molitor Jerry A., Henstorf Gretchen, Lafyatis Robert, Pritchard David K., Adams Lawrence D., Furst Daniel E., Schwartz Stephen M.
Primary Institution: Department of Pathology, University of Washington, Seattle, Washington, United States of America
Hypothesis
Can stem cell therapy reverse capillary loss in scleroderma?
Conclusion
The study provides evidence that capillary loss in scleroderma is reversible following high-dose immunosuppressive therapy and autologous hematopoietic cell transplantation.
Supporting Evidence
- Scleroderma patients showed a significant loss of capillaries compared to normal controls.
- Five out of seven patients treated with stem cell therapy had increased capillary counts.
- Markers of endothelial function returned to normal in patients who improved clinically after treatment.
Takeaway
Scleroderma patients can lose tiny blood vessels in their skin, but a special treatment can help them grow back.
Methodology
The study used immunohistochemical and mRNA in situ hybridization techniques to analyze skin biopsies from scleroderma patients and normal controls.
Potential Biases
Potential bias due to the retrospective design and limited tissue availability.
Limitations
The study was limited by the retrospective nature and the small sample size.
Participant Demographics
Participants included 23 scleroderma patients and 24 normal controls, with additional biopsies from 7 patients post-treatment.
Statistical Information
P-Value
p=0.01 for Ulex europaeus lectin
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website